Miers Johnson, MD
Orthopaedic Surgery · Nampa, IDNPI 1942291521
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $15,237 of the $18,043 with a category attached, or 84.4%. Medacta USA, Inc. accounts for 73.4% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $12,255 and has fallen 98.2% since, to $215 in 2024.
Across 75 payments — averaging $240.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$13K
- Arthrex$2K
- Zimmer Biomet$817
- Stryker$539
- Steelhead Surgical Inc$416
- Johnson & Johnson$221
- plus $543 from 9 others
What the payments were for
- Travel & lodging$15,23784%
- Food & beverage$2,80716%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 13 | $13,245 |
| Arthrex | 19 | $2,263 |
| Zimmer Biomet | 10 | $817 |
| Stryker | 13 | $539 |
| Steelhead Surgical Inc | 4 | $416 |
| Johnson & Johnson | 2 | $221 |
| Medical Device Business Services, Inc. | 2 | $192 |
| Shoulder Innovations, Inc. | 2 | $166 |
| Pacira Pharmaceuticals Incorporated | 2 | $38 |
| Smith+Nephew | 2 | $34 |
| Heron Therapeutics, Inc. | 2 | $31 |
| Acumed LLC | 1 | $25 |
| Bioventus LLC | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$9,693
- GMK$2,555
- Comprehensive Primary Stem$533
- AMISTEM$365
- MYKNEE$273
- InSet System$149
- ATTUNE$124
- ME1000 Surgical Impactor$124
- REVERSE SHOULDER$119
- Comp Primary Revision Stem$115
- Comprehensive Reverse$105
How this compares
$18,043 in reported general payments places this provider in the 80th percentile of 139 orthopaedic surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 36 | $191 |
| Oxycodone Hcl | 19 | $133 |
| Ondansetron Hcl | 14 | $96 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $39 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Nampa
- Charles ClarkNampa$27K
- Carl HumphreyEagle$9.4M
- Richard MooreBoise$7.4M
- Roman SchwartsmanBoise$358K
- Lucas AndersonCoeur D Alene$243K
- Jeffry MenznerBoise$194K
- Justin DazleyTwin Falls$184K
- Christopher HiroseBoise$182K
- Joseph LynchBoise$140K
- Tracye LawyerBoise$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.